A quantitative system for discriminating induced pluripotent stem cells, embryonic stem cells and somatic cells
Anyou Wang

TL;DR
This paper presents a robust, quantitative DNA methylation-based system using machine learning models to accurately discriminate between induced pluripotent stem cells, embryonic stem cells, and somatic cells across various platforms and subtypes.
Contribution
The study introduces a novel, unbiased DNA methylation biomarker-based framework combined with neural networks and SVMs for precise cell type discrimination.
Findings
Achieves nearly 100% accuracy in distinguishing SCs from ESCs and iPSCs with minimal biomarkers.
Discriminates ESCs from iPSCs with 95% accuracy using around 100 biomarkers.
Effective across different data platforms and cell subtypes, including gender and developmental stages.
Abstract
Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) derived from somatic cells (SCs) provide promising resources for regenerative medicine and medical research, leading to a daily identification of new cell lines. However, an efficient system to discriminate the cell lines is lacking. Here, we developed a quantitative system to discriminate the three cell types, iPSCs, ESCs and SCs. The system contains DNA-methylation biomarkers and mathematical models, including an artificial neural network and support vector machines. All biomarkers were unbiasedly selected by calculating an eigengene score derived from analysis of genome-wide DNA methylations. With 30 biomarkers, or even with as few as 3 top biomarkers, this system can discriminate SCs from ESCs and iPSCs with almost 100% accuracy, and with approximately 100 biomarkers, the system can distinguish ESCs from iPSCs…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
